Slavica Milorad Eric

Prof. Dr. Slavica Milorad Eric


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2022 in Nanotechnology
Verified
Journal Article
Closed access
AVAleksandar Vukadinović
Aleksandar Vukadinović
ZMZorana Milanović
Zorana Milanović
Miloš OgnjanovićMiloš Ognjanović
Miloš Ognjanović
DJDrina Janković
Drina Janković
MRMagdalena Radović
Magdalena Radović
ZPZeljko Prijovic
Zeljko Prijovic
Radiolabelled superparamagnetic iron oxide nanoparticles (SPIONs) are a promising nanomaterial for the development of dual radiation/hyperthermia cancer therapy. To that purpose, flower-shaped SPIONs with an exceptional heating capability were synthesised and coated with citrate, dextran or (3-aminopropyl)triethoxysilane. Both non-coated and coated SPIONs were nontoxic to CT-26 mouse colon cancer cells up to 1.0 mg ml −1 in vitro . In an oscillating magnetic field, citrate-coated SPIONs (CA/SPIONs) displayed the highest heating rate ( SAR ∼ 253 W g −1 ) and the strongest hyperthermia effects against CT-26 cells. Labelling of the CA/SPIONs by the 90 Y radionuclide, emitting β − radiation with an average/maximum energy of 0.94/2.23 MeV, and deep tissue penetration generated 90 Y-CA/SPIONs intended for the therapy of solid tumours. However, intravenous injection of 90 Y-CA/SPIONs in CT-26 xenograft-bearing mice resulted in low tumour accumulation. On the contrary, intratumoural injection resulted in long-term retention at the injection site. A single intratumoural injection of 0.25 mg CA/SPIONs followed by 30-min courses of magnetic hyperthermia for four consecutive days caused a moderate antitumour effect against CT-26 and 4T1 mouse tumour xenografts. Intratumoural application of 1.85 MBq/0.25 mg 90 Y-CA/SPIONs, alone or combined with hyperthermia, caused a significant ( P ≤ 0.01) antitumour effect without signs of systemic toxicity. The results confirm the suitability of 90 Y-CA/SPIONs for monotherapy or dual magnetic hyperthermia-radionuclide nanobrachytherapy (NBT) of solid tumours.

1 January 2021 in Journal of the Serbian Chemical Society
Verified
Journal Article
Open access
PDF file
MSMilena R Simić
Milena R Simić
SESlavica Milorad Eric
Slavica Milorad Eric
IBIvan Boric
Ivan Boric
ALAnnamaria Lubelska
Annamaria Lubelska
GLGniewomir Latacz
Gniewomir Latacz
VSVladimir M. Savić
Vladimir M. Savić
In the continuation of our study of substituted isocoumarins a series of novel 3-azolyl isocoumarin and their thio derivatives, including some related lactone compounds was prepared and biologically profiled against C. albicans showing moderate activity with MIC values in range of 4?60 ?g mL-1, in general. The additional characterisation of selected compounds was carried out by exploring their activity on CYP3A4 and CYP2D6 enzymes, while experiments on mutagenicity were performed by AMES test. The representative isocoumarins 3b, 4a and 4b showed lower inhibitory activity on CYP enzymes, when compared to the reference inhibitors, ketoconazole and quinidine. Compound 4a showed a higher mutagenic potential than the other two compounds. Further characterization included cytotoxicity profiling against normal MRC5 cells.

1 May 2004 in Il Farmaco
Verified
Journal Article
Closed access
SESlavica Milorad Eric
Slavica Milorad Eric
TST. Solmajer
T. Solmajer
JZJ. Zupan
J. Zupan
MNM. Novic
M. Novic
MOM. Oblak
M. Oblak
DAD. Agbaba
D. Agbaba

27 January 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
AVAleksandar Vukadinovic
Aleksandar Vukadinovic
Miloš OgnjanovićMiloš Ognjanović
Miloš Ognjanović
MMMilica Mijović
Milica Mijović
BWBryce Warren
Bryce Warren
SESlavica Milorad Eric
Slavica Milorad Eric
ZPZeljko Prijovic
Zeljko Prijovic
Background: The rapid rise in cancer incidence significantly augments efforts to improve cancer treatments. A multimodal approach in the nanobrachytherapy of solid tumors is one of the promising methods under investigation. This study presents a novel biocompatible lignin-based nanomaterial, loaded with cytostatic agent SN-38 and radionuclide 131I, for simultaneous radiation and chemotherapy of solid tumors by a nanobrachytherapy approach. Method: Nanoparticles of ~100 nm in size, composed of lignin alone or loaded with 10% (m/m) of SN-38 (SN-38@lignin), were synthesized using a bottom-up approach and characterized. Subsequent radiolabeling of the nanoparticles by 131I produced 131I-lignin and 131I-SN-38@lignin. Their antitumor efficiency was tested against luciferase-expressing 4T1 mouse breast cancer xenografts of ~100 mm3 size on Balb/c mice. Results: An intratumoral injection of 1.85 MBq of 131I-lignin was retained within the tumor and achieved a moderate twofold decrease in tumor size compared to the control group. Injecting SN-38@lignin containing 25 µg of SN-38 decreased tumor size 3.5-fold. The therapy using the same doses of 131I-SN-38@lignin produced the most potent antitumor effect, with tumors being 6-fold smaller and having extensive intratumoral necrosis, all of it without signs of systemic toxicity. Conclusions: These results support the intratumoral delivery of lignin-based nanomaterial carrying radioisotopes and camptothecins for effective multimodal anticancer therapy.

1 January 2024 in Arhiv za farmaciju
Verified
Journal Article
Open access
PDF file
MSMilena R Simić
Milena R Simić
SESlavica Milorad Eric
Slavica Milorad Eric
A series of recently synthetized and biologically evaluated isocoumarin derivatives (n=16, including voriconazole as standard) were used for heuristic analysis of structure, activity and selectivity relationships. While research of isocoumarins found in the literature was mainly focused on antifungal properties of 3-alkyl/aryl compounds, this study used structures synthetized by a strategy merging antifungal properties of isocoumarins with some known fungal pharmacophores. Rationalization of activity and selectivity was performed using the results of testing against C. albicans (CA) and testing on a normal human lung fibroblast cell line (MRC5). Structures were created and optimized using the ChemDraw Ultra 8.0 and MOPAC software. Calculation of molecular descriptors and the heuristic method, using the Codessa software, were applied for the selection of the most significant descriptors for activity against CA, as well as selectivity against CA versus MRC5. Biological tests for determination of activity against CA used in studies include inhibition of hyphal growth, so the activity against resistant cells was also considered. The supposed mechanisms of action, including lacton opening and electrophilic attack on nucleophiles, as well as inhibition of lanosterol 14a-demethylase (CYP51), were in agreement with the results obtained. The results could serve as a basis for further optimization of isocoumarin derivatives with respect to better activity, selectivity and action against resistant species.